SCHEMBL22019098

SCHEMBL22019098

N#Cc1cc(Cl)cc2c1oc1c(-c3ccccc3)cccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ MAOA P21397 2/20 0.38
▸ MAOB P27338 1/20 0.38
▸ PRKDC P78527 6/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ PIK3CD O00329 2/20 0.36
▸ PIK3CA P42336 2/20 0.36
▸ PIK3CB P42338 2/20 0.36
▸ PIK3CG P48736 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ BRD4 O60885 2/20 0.36
▸ BRD2 P25440 2/20 0.36
▸ BRD3 Q15059 2/20 0.36
▸ TP53 P04637 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ NFKB1 P19838 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21583617 0.83 ESR2 (0.41) CYP1A2CYP2C9CYP2C19PRKDCALDH1A1
SCHEMBL16558207 0.80 ESR2 (0.40) CYP1A2CYP2C9CYP2C19NPSR1PRKDC
SCHEMBL29293267 0.79 PRKDC (0.43) CYP1A2CYP2C9CYP2C19PRKDCALDH1A1
SCHEMBL22117455 0.79 PRKDC (0.39) CYP1A2CYP2C9CYP2C19MAOBPRKDC
SCHEMBL24352226 0.78 KDM4E (0.43) PRKDCALDH1A1SMN1; SMN2KDM4ETP53
SCHEMBL16560676 0.77 PRKDC (0.36) CYP1A2CYP2C9CYP2C19PRKDCALDH1A1
SCHEMBL21795012 0.77 AHR (0.50) ALDH1A1SMN1; SMN2KDM4ELMNAAHR
SCHEMBL26639965 0.77 PRKDC (0.41) CYP1A2CYP2C9CYP2C19PRKDCALDH1A1
SCHEMBL30657619 0.77 PRKDC (0.41) CYP1A2CYP2C9CYP2C19PRKDCALDH1A1
SCHEMBL16558204 0.77 KCNA3 (0.39) CYP1A2CYP2C9CYP2C19NPSR1PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220020932-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-01-20 — — US disclosed
WO-2020101169-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF 덕산네오룩스 주식회사 2020-05-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220020932-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR51E2, OR10J3 CYP1A2 901/4885CYP2C9 423/4885CYP2C19 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback